AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyAnimal studyNot reportedPublished in a peer-reviewed journal
Investigating IgG N-glycosylation in Animal and Human Studies
Increased IgG agalactosylation correlates with inflammatory diseases such as multiple sclerosis, with changes in IgG N-glycans typically preceding disease onset and flare-ups.
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
Understanding these changes could help elucidate disease mechanisms and potential biomarkers for autoimmune conditions. However, the exact role that IgG N-glycans play in inflammation remains unclear, limiting their application in clinical settings.
What this does not prove
The mechanism by which IgG N-glycans are involved in inflammation is not understood, leaving a gap in potential therapeutic targeting.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-05
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceIgG N-glycosylation in autoimmune diseases. ↗DOI: 10.3389/fimmu.2026.1933960
Supporting passages (5)
findingsChanges to the IgG N-glycan typically accompany and often precede disease onset and flare-ups, while they decrease in remission and pregnancy.
limitationsYet, despite the association with inflammation, any mechanism by which disease-associated IgG N-glycans may mediate their pro-inflammatory nature remains enigmatic.
publication datePublication date: 2026-10-05
peer reviewedPublication types: Journal Article; Review; Research Support, N.I.H., Extramural
subjectsMeSH terms: Humans; Autoimmune Diseases; Glycosylation; Immunoglobulin G; Animals; Polysaccharides
AI assessment, not yet reviewed by a person · version 3 · Community votes are separate from evidence review.